Literature DB >> 19487393

Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.

Philip D Harvey1, Lars Helldin, Christopher R Bowie, Robert K Heaton, Anna-Karin Olsson, Fredrik Hjärthag, Torsten Norlander, Thomas L Patterson.   

Abstract

OBJECTIVE: Recent advances in the assessment of disability in schizophrenia have separated the measurement of functional capacity from real-world functional outcomes. The authors examined the similarity of performance-based assessments of everyday functioning, real-world disability, and achievement of milestones in people with schizophrenia in the United States and Sweden.
METHOD: The UCSD Performance-Based Skills Assessment-Brief Version (UPSA-B) and a neuropsychological assessment were administered to schizophrenia patients living in rural areas in Sweden (N=146) and in the New York City area (N=244), and patients' functioning was rated by their case managers. Information from records and case managers was used to determine the frequency of living independently, working, and having ever experienced a stable romantic relationship.
RESULTS: Performance on the UPSA-B was essentially identical in the two samples (New York, mean score=13.84; Sweden, mean score=13.30), as were scores on the case manager ratings of everyday activities (New York, mean=49.0; Sweden, mean=48.8). The correlations between UPSA-B score, neuropsychological test performance, and case manager ratings did not differ across the two samples. The proportion of patients who had never had a close relationship and the rate of vocational disability were also nearly identical. However, while 80% of the Swedish patients were living independently, only 46% of the New York patients were.
CONCLUSIONS: While scores on performance-based measures of everyday living skills were similar in people with schizophrenia across cultures, real-world residential outcomes were very different. These data suggest that cultural and social support systems can lead to divergent real-world outcomes among individuals who show evidence of the same levels of ability and potential.

Entities:  

Mesh:

Year:  2009        PMID: 19487393      PMCID: PMC3667206          DOI: 10.1176/appi.ajp.2009.09010106

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  SLOF: a behavioral rating scale for assessing the mentally ill.

Authors:  L C Schneider; E L Struening
Journal:  Soc Work Res Abstr       Date:  1983

3.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

Authors:  N C Andreasen; M Flaum; S Arndt
Journal:  Arch Gen Psychiatry       Date:  1992-08

4.  Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis.

Authors:  Elizabeth W Twamley; Rishi R Doshi; Gauri V Nayak; Barton W Palmer; Shahrokh Golshan; Robert K Heaton; Thomas L Patterson; Dilip V Jeste
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

5.  Cognitive impairment in geriatric chronic schizophrenic patients: a cross-national study in New York and London.

Authors:  P D Harvey; J Leff; N Trieman; J Anderson; M Davidson
Journal:  Int J Geriatr Psychiatry       Date:  1997-10       Impact factor: 3.485

6.  Evaluation of social problem solving in schizophrenia.

Authors:  A S Bellack; M Sayers; K T Mueser; M Bennett
Journal:  J Abnorm Psychol       Date:  1994-05

7.  Barriers to employment for people with schizophrenia.

Authors:  Robert Rosenheck; Douglas Leslie; Richard Keefe; Joseph McEvoy; Marvin Swartz; Diana Perkins; Scott Stroup; John K Hsiao; Jeffrey Lieberman
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

8.  Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome.

Authors:  Philip D Harvey; Richard S E Keefe; Thomas L Patterson; Robert K Heaton; Christopher R Bowie
Journal:  J Clin Exp Neuropsychol       Date:  2009-05       Impact factor: 2.475

9.  Disability compensation and work among veterans with psychiatric and nonpsychiatric impairments.

Authors:  R Rosenheck; L Frisman; J Sindelar
Journal:  Psychiatr Serv       Date:  1995-04       Impact factor: 3.084

10.  Assessing disability in older patients with schizophrenia: results from the WHODAS-II.

Authors:  Christine McKibbin; Thomas L Patterson; Dilip V Jeste
Journal:  J Nerv Ment Dis       Date:  2004-06       Impact factor: 2.254

View more
  48 in total

1.  Risk factors for psychosis: impaired social and role functioning.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Jean Addington; Larry Seidman; Elaine F Walker; Tyronne D Cannon; Kristin S Cadenhead; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Robert Heinssen; Todd Lencz
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 2.  Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation.

Authors:  Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

3.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

Review 4.  Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness.

Authors:  Thomas L Patterson; Brent T Mausbach
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

5.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Authors:  Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

6.  Anticipating DSM-V: opportunities and challenges for cognition and psychosis.

Authors:  Deanna M Barch; Richard S E Keefe
Journal:  Schizophr Bull       Date:  2009-11-18       Impact factor: 9.306

Review 7.  Update: schizophrenia across cultures.

Authors:  Neely Laurenzo Myers
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

8.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

9.  Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  J Int Neuropsychol Soc       Date:  2013-02-21       Impact factor: 2.892

10.  The convergence between self-reports and observer ratings of financial skills and direct assessment of financial capabilities in patients with schizophrenia: more detail is not always better.

Authors:  Philip D Harvey; Laura Stone; David Lowenstein; Sara J Czaja; Robert K Heaton; Elizabeth W Twamley; Thomas L Patterson
Journal:  Schizophr Res       Date:  2013-03-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.